188 related articles for article (PubMed ID: 33530461)
21. Clinical relevance of CHEK2 and NBN mutations in the macedonian population.
Kostovska IM; Jakimovska M; Kubelka-Sabit K; Karadjozov M; Arsovski A; Stojanovska L; Plaseska-Karanfilska D
Balkan J Med Genet; 2015 Jun; 18(1):47-54. PubMed ID: 26929905
[TBL] [Abstract][Full Text] [Related]
22. CHEK2-positive breast cancers in young Polish women.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Kowalska E; Oszurek O; Narod SA; Lubinski J
Clin Cancer Res; 2006 Aug; 12(16):4832-5. PubMed ID: 16914568
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention.
Cybulski C; Huzarski T; Byrski T; Gronwald J; Debniak T; Jakubowska A; Górski B; Wokołorczyk D; Masojć B; Narod SA; Lubiński J
Clin Genet; 2009 Jan; 75(1):72-8. PubMed ID: 19021634
[TBL] [Abstract][Full Text] [Related]
24. An association study between CHEK2 gene mutations and susceptibility to breast cancer.
Jalilvand M; Oloomi M; Najafipour R; Alizadeh SA; Saki N; Rad FS; Shekari M
Comp Clin Path; 2017; 26(4):837-845. PubMed ID: 28680382
[TBL] [Abstract][Full Text] [Related]
25. A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia.
Scharrer U; Skrzypczak-Zielinska M; Wituszynska W; Mierzejewski M; Krause K; Cybulski C; Froster UG
Cancer Genet Cytogenet; 2010 May; 199(1):48-52. PubMed ID: 20417869
[TBL] [Abstract][Full Text] [Related]
26.
Brock P; Liynarachchi S; Nieminen TT; Chan C; Kohlmann W; Stout LA; Yao S; La Greca A; Jensen KE; Kolesar JM; Salhia B; Gulhati P; Hicks JK; Ringel MD
Thyroid; 2024 Apr; 34(4):477-483. PubMed ID: 38279823
[No Abstract] [Full Text] [Related]
27. A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations.
Janiszewska H; Bak A; Pilarska M; Heise M; Junkiert-Czarnecka A; Kuliszkiewicz-Janus M; Całbecka M; Jaźwiec B; Wołowiec D; Kuliczkowski K; Haus O
Haematologica; 2012 Mar; 97(3):366-70. PubMed ID: 22058216
[TBL] [Abstract][Full Text] [Related]
28. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
[TBL] [Abstract][Full Text] [Related]
29. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Zdrojowy R; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Narod SA; Lubiński J
J Med Genet; 2006 Nov; 43(11):863-6. PubMed ID: 17085682
[TBL] [Abstract][Full Text] [Related]
30. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
31. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J
Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985
[TBL] [Abstract][Full Text] [Related]
32. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
[TBL] [Abstract][Full Text] [Related]
33. Association of two mutations in the CHEK2 gene with breast cancer.
Bogdanova N; Enssen-Dubrowinskaja N; Feshchenko S; Lazjuk GI; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Dörk T
Int J Cancer; 2005 Aug; 116(2):263-6. PubMed ID: 15810020
[TBL] [Abstract][Full Text] [Related]
34. Pathology of breast cancer in women with constitutional CHEK2 mutations.
Huzarski T; Cybulski C; Domagała W; Gronwald J; Byrski T; Szwiec M; Woyke S; Narod SA; Lubiński J
Breast Cancer Res Treat; 2005 Mar; 90(2):187-9. PubMed ID: 15803365
[TBL] [Abstract][Full Text] [Related]
35. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
[TBL] [Abstract][Full Text] [Related]
36. Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
van Puijenbroek M; van Asperen CJ; van Mil A; Devilee P; van Wezel T; Morreau H
J Pathol; 2005 Jun; 206(2):198-204. PubMed ID: 15818573
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.
Schmidt MK; Tollenaar RA; de Kemp SR; Broeks A; Cornelisse CJ; Smit VT; Peterse JL; van Leeuwen FE; Van't Veer LJ
J Clin Oncol; 2007 Jan; 25(1):64-9. PubMed ID: 17132695
[TBL] [Abstract][Full Text] [Related]
38.
Švajdler P; Vasovčák P; Švajdler M; Šedivcová M; Urbán V; Michal M; Mezencev R
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267514
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy.
Meyer A; Dörk T; Sohn C; Karstens JH; Bremer M
Radiother Oncol; 2007 Mar; 82(3):349-53. PubMed ID: 17250914
[TBL] [Abstract][Full Text] [Related]
40. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
